Login / Signup

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Giovanni TargherAlessandro MantovaniChristopher D ByrneXiao-Bo WangHua-Dong YanQing-Feng SunKe-Hua PanKenneth I ZhengYong-Ping ChenMohammed EslamJacob GeorgeMing-Hua Zheng
Published in: Gut (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • oxidative stress
  • early onset
  • fatty acid
  • respiratory syndrome coronavirus
  • liver fibrosis